comparemela.com

Latest Breaking News On - Controlled trials - Page 1 : comparemela.com

Melatonin Not Supported to Treat ICU Delirium, SCD; Other Agents May Hold Promise

Melatonin Not Supported to Treat ICU Delirium, SCD; Other Agents May Hold Promise
psychiatryadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatryadvisor.com Daily Mail and Mail on Sunday newspapers.

Cochrane-central-register
Controlled-trials
Cochrane-database
Systematic-reviews
Science-core-collection
Confusion-assessment-method
Intensive-care-delirium-screening-checklist

Can vitamin D3 supplementation reduce COVID-19 severity?

Can vitamin D3 supplementation reduce COVID-19 severity?
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Spain
Croatia
Switzerland
Argentina
Mexico
Belgium
Russia
Iran
France
Egypt
Brazil
Oldesign-shutterstock

Melatonin Not Supported to Treat ICU Delirium, SCD; Other Agents May Hold Promise

Melatonin Not Supported to Treat ICU Delirium, SCD; Other Agents May Hold Promise
neurologyadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from neurologyadvisor.com Daily Mail and Mail on Sunday newspapers.

Cochrane-central-register
Controlled-trials
Cochrane-database
Systematic-reviews
Science-core-collection
Confusion-assessment-method
Intensive-care-delirium-screening-checklist

Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis

Objective To determine the efficacy of psilocybin as an antidepressant compared with placebo or non-psychoactive drugs. Design Systematic review and meta-analysis. Data sources Five electronic databases of published literature (Cochrane Central Register of Controlled Trials, Medline, Embase, Science Citation Index and Conference Proceedings Citation Index, and PsycInfo) and four databases of unpublished and international literature (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ProQuest Dissertations and Theses Global, and PsycEXTRA), and handsearching of reference lists, conference proceedings, and abstracts. Data synthesis and study quality Information on potential treatment effect moderators was extracted, including depression type (primary or secondary), previous use of psychedelics, psilocybin dosage, type of outcome measure (clinician rated or self-reported), and personal characteristics (eg, age, sex). Data were synthesised using a random effects me

Athina
Attikír
Greece
Mike-clarke
Marina-metaxa
University-of-oxford-nuffield-department-medicine
Department-for-continuing-education
International-prospective-register-of-systematic
International-clinical-trials-registry-platform
University-of-oxford-msc
Athina-marina-metaxa
Am-metaxa

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.